These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11358078)

  • 1. Applications of magnetic resonance spectroscopy to chronic liver disease.
    Taylor-Robinson SD
    Clin Med (Lond); 2001; 1(1):54-60. PubMed ID: 11358078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and applications of in vivo clinical magnetic resonance spectroscopy.
    Cox IJ
    Prog Biophys Mol Biol; 1996; 65(1-2):45-81. PubMed ID: 9029941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RETRACTED ARTICLE: Diagnosis of rejection after liver transplantation: use of phosphorus-31 magnetic resonance spectroscopy ((31)P-MRS).
    Jiang T; Liu S; Xiao X; Tao X; Liu G; Wang J
    Abdom Imaging; 2012 Oct; 37(5):788-94. PubMed ID: 23166917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications.
    Khan SA; Cox IJ; Hamilton G; Thomas HC; Taylor-Robinson SD
    Liver Int; 2005 Apr; 25(2):273-81. PubMed ID: 15780050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viability assessment of magnetic resonance spectroscopy for the detection of minimal hepatic encephalopathy severity.
    Meng LP; Chen YC; Li YH; Zhu JS; Ye JL
    Eur J Radiol; 2015 Oct; 84(10):2019-23. PubMed ID: 26170124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic Resonance Spectroscopy: Principles and Techniques: Lessons for Clinicians.
    Tognarelli JM; Dawood M; Shariff MI; Grover VP; Crossey MM; Cox IJ; Taylor-Robinson SD; McPhail MJ
    J Clin Exp Hepatol; 2015 Dec; 5(4):320-8. PubMed ID: 26900274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities of the liver evaluated by 31P MRS.
    Meyerhoff DJ; Karczmar GS; Weiner MW
    Invest Radiol; 1989 Dec; 24(12):980-4. PubMed ID: 2606636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR imaging and spectroscopy of the basal ganglia in chronic liver disease: correlation of T1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra.
    Taylor-Robinson SD; Sargentoni J; Oatridge A; Bryant DJ; Hajnal JV; Marcus CD; Seery JP; Hodgson HJ; deSouza NM
    Metab Brain Dis; 1996 Sep; 11(3):249-68. PubMed ID: 8869945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic 31P MRS in rat models of chronic liver disease: assessing the extent and progression of disease.
    Corbin IR; Buist R; Peeling J; Zhang M; Uhanova J; Minuk GY
    Gut; 2003 Jul; 52(7):1046-53. PubMed ID: 12801965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy.
    Grover VP; Dresner MA; Forton DM; Counsell S; Larkman DJ; Patel N; Thomas HC; Taylor-Robinson SD
    World J Gastroenterol; 2006 May; 12(19):2969-78. PubMed ID: 16718775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease.
    Cox IJ; Sharif A; Cobbold JF; Thomas HC; Taylor-Robinson SD
    World J Gastroenterol; 2006 Aug; 12(30):4773-83. PubMed ID: 16937457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve.
    Lee JH; Seo DW; Lee YS; Kim ST; Mun CW; Lim TH; Min YI; Suh DJ
    Am J Gastroenterol; 1999 Aug; 94(8):2206-13. PubMed ID: 10445551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance spectroscopy in the study of hyperammonemia and hepatic encephalopathy.
    Kanamori K; Bluml S; Ross B
    Adv Exp Med Biol; 1997; 420():185-94. PubMed ID: 9286434
    [No Abstract]   [Full Text] [Related]  

  • 14. Minimal hepatic encephalopathy in patients with liver cirrhosis: magnetic resonance spectroscopic brain findings versus neuropsychological changes.
    Hassan EA; Abd El-Rehim AS; Seifeldein GS; Shehata GA
    Arab J Gastroenterol; 2014; 15(3-4):108-13. PubMed ID: 25459346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton magnetic resonance spectroscopy in portal-systemic encephalopathy.
    Köstler H
    Metab Brain Dis; 1998 Dec; 13(4):291-301. PubMed ID: 10206821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer.
    Dagnelie PC; Leij-Halfwerk S
    World J Gastroenterol; 2010 Apr; 16(13):1577-86. PubMed ID: 20355236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does magnetic resonance spectroscopy identify patients with minimal hepatic encephalopathy?
    Ciećko-Michalska I; Dziedzic T; Banyś R; Senderecka M; Binder M; Wyczesany M; Szewczyk J; Wójcik J; Słowik A; Mach T
    Neurol Neurochir Pol; 2012; 46(5):436-42. PubMed ID: 23161187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts.
    Taylor-Robinson SD; Sargentoni J; Bell JD; Thomas EL; Marcus CD; Changani KK; Saeed N; Hodgson HJ; Davidson BR; Burroughs AK; Rolles K; Foster CS; Cox IJ
    Gut; 1998 May; 42(5):735-43. PubMed ID: 9659173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy.
    Guevara M; Baccaro ME; Gómez-Ansón B; Frisoni G; Testa C; Torre A; Molinuevo JL; Rami L; Pereira G; Sotil EU; Córdoba J; Arroyo V; Ginès P
    J Hepatol; 2011 Sep; 55(3):564-573. PubMed ID: 21163310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal hepatic encephalopathy diagnosis by magnetic resonance spectroscopy. A case report.
    Scheau C; Bădărău AI; Gherguş AE; Popa GA; Lupescu IG
    J Gastrointestin Liver Dis; 2013 Dec; 22(4):455-9. PubMed ID: 24369330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.